For citations:
Imawari M., Nagase M., Torshin I.Yu., Gromova O.A. An open-label, controlled trial of the clinical effects of Laennec® in patients with nonalcoholic steatohepatitis or cirrhosis. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2023;16(3):447-455. (In Russ.) https://doi.org/10.17749/2070-4909/farmakoekonomika.2023.206
Views PDF (Rus): 216
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 